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delineated on 4 kilovoltage-CT: Inspiration, expiration and free-breath± contrast by using Civco® Pro-lok abdominal compres-
sion system, was the internal tumor volume (ITV). Planned treatment volume (PTV) consisted of 5-mm radial and a 10-mm
craniocaudal expansion of ITV. The prescribed doses were: 3×20Gy, 3×18Gy, 8×7.5Gy. Dose constraints to normal tissue were
deﬁned accord to RTOG 0236 protocol. To asses intrafraction tumor motion, megavoltage-CT (MVCT) scan was obtained prior to
and at the end of each fraction (in patients receiving 18–20Gy/fraction a MVCT was performed in the middle of the delivered
treatment). The prior MVCT was matched with the kilovoltage-CT planning to check if corrections had to be done.
Results. The mean fraction treatment time was 1Gy/1 min. In 2 patients multiple targets were simultaneously treated. To asses
intra-fraction tumor motion we matched prior-MVCT, mid-MVCT and end-MVCT scan and we checked that PTVs were included
within isodose of prescription dose in all cases. Mean correction after MVCT registration was 2 mm. One late ﬁbrosis with
transitory neuroalgic pain has been observed. All lesions are controlled at the time of analysis and one patient died by other
causes and four patients are alive with disease.
Conclusions. HT-SBRT is feasible and well tolerated treatment in lung tumors and image guidance with MVCT allowed daily
position correction and precise treatment delivery.
http://dx.doi.org/10.1016/j.rpor.2013.03.321
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Introduction. Stereotactic body radiotherapy is an emergingnoninvasive technique for the treatment of lung lesions.Whenpatients
with non-small lung cancer are unable to tolerate the rigors of surgery due to lack of adequate respiratory reserve, SBRT offers
a radical option of treatment.
Objective. To describe and evaluate initial experience of SBRT for medically inoperable primary or recurrent lung cancer at our
institution.
Material/Methods. From May’12 to January’13, 15 lesions in 13 patients were irradiated. 2/13 patients presented recurrent lung
cancer and they had been previously irradiated. All patients had difﬁculty breathing. Each patient was immobilized with abdom-
inal compressor and vacuum cushion. An ITV was deﬁned using three CT scans with references to the phases of respiration and
the PTV was obtained by uniformly 5 mm ITV expanding. The dose to PTV was escalated from 50 to 60Gy in 5 fractions mainly.
8 patient treatments were perfomed on a Clinac iXTM and 5 treatments on a TruebeamTM with high deﬁnition MLC. Volumetric
modulated arc therapy (RapidArcTM) was used in 12/13 patients, and image-guided RT was performed with cone-beam CT (CBCT).
Intra-fraction movement was controlled by post-treatment CBCT.
Results. Median age was 74 (46–87). The median GTV/PTV size was 17.77/77.48 cm3 (1.28–129.95/18.08–263.39). The median D95%
of the PTV was 53.34Gy and median V20, V10 and V5 of both lungs were 7.38%, 13.8% and 23.8% respectively. Intra-fraction
movement in all cases was less than 2.4 mm. Only one patient presented deterioration of his usual dyspnea. Clinical outcomes
of 7 patients with more than 3 months of follow-up were collected. At a median follow-up of 6 (3–8) months, no local progression
was observed with 3/7 complete responses. Regional and distant failure were developed by 2 and 1 patients respectively.
Conclusions. Although the short follow-up, SBRT seems an effective and safe option for medically inoperable lung cancer patients.
http://dx.doi.org/10.1016/j.rpor.2013.03.322
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Introduction. We present a series of patients treated with lung SBRT introduced in our clinics since 2009 to date. Target Analyze
dosimetric aspects, acute toxicity and response obtained.
Materials and methods. CT-simulation c/c IV (slice thickness) with body stereotactic body frame (ELEKTA®) mattress individualized
and diaphragmatic compression. Post-immobilization ﬂuoroscopy to determine three-dimensional displacement and decides
PTV margins. Use lung-window/level for Identify the lesion. Image Fusion (PET-CT). SYNERGY® multi-energy linear accelerator.
Isocenter stereotactic localization (Dynatrac®). Robotic table (6 degrees of freedom-Hexapod®). Image-guided Radiotherapy (IGRT)
cone beam. We performed 30 treatments in 13 patients (p) 7 with several locations: 6 p 2–5 lesions treated and 1 simultaneous
multiplemetastaseswas treated three times from2009 to 2012 (melanoma). 5 treatments are primary,metastatic rest. Histology: 2
